Allergic Rhinitis

Pipeline Assessment and Market Forecasts to 2017

Product Code GDA00734
Publication Date July 2010
Publisher GlobalData
Product Type Report
Pages 46
ISBN Number not applicable
Change currency
PDF £1,265.00 €1,523 $2,000 BUY >
Order by fax
Ask a question about this product > Receive product alerts > Call now +44 20 7060 7474

Allergic Rhinitis

Pipeline Assessment and Market Forecasts to 2017

GlobalData, the industry analysis specialist, has released a new report, ""Allergic Rhinitis - Pipeline Assessment and Market Forecasts to 2017"". The report is an essential source of information and analysis on the global allergic rhinitis market. The report identifies the key trends shaping and driving the global allergic rhinitis market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to significantly shift the market positioning of the existing market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global allergic rhinitis sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData's team of industry experts.

Scope

The report provides information on the key drivers and challenges of the global allergic rhinitis market. Its scope includes:

  • Annualized global allergic rhinitis market revenues data from 2001 to 2009, forecast for eight years to 2017.
  • Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends. The key mechanisms of action include histamine antagonists, anti-inflammatory agents, corticosteroids and immunomodulators.
  • Analysis of the current and future market competition in the global allergic rhinitis market. The key market players covered are Merck & Co, GlaxoSmithKline, AstraZeneca, Novartis AG, Sanofi-Aventis and HAL Allergy.
  • Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
  • Key topics covered include a strategic competitor assessment, market characterization, unmet needs and the implications for the allergic rhinitis therapeutics market.

Reasons to buy

The report will enhance your decision making capability. It will allow you to:

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving the global allergic rhinitis market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global allergic rhinitis market in future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
  • What's the next big thing in the global allergic rhinitis market? - Identify, understand and capitalize

Contents

  • 1 Table of Contents
    • 1.1 List of Tables
    • 1.2 List of Figures
  • 2 Allergic Rhinitis Market: Market Characterization
    • 2.1 Disease Overview
    • 2.2 Allergic Rhinitis Market Size
    • 2.3 Allergic Rhinitis Market Forecast and CAGR
    • 2.4 Drivers and Barriers for the Allergic Rhinitis Market
    • 2.4.1 Drivers for the Allergic Rhinitis Market
    • 2.4.2 Barriers for the Allergic Rhinitis Market
    • 2.5 Opportunity and Unmet Need
    • 2.6 Key Takeaway
  • 3 Allergic Rhinitis Market: Competitive Assessment
    • 3.1 Overview
    • 3.2 Strategic Competitor Assessment
    • 3.3 Product Profile for the Major Marketed Products in the Allergic Rhinitis Market
    • 3.3.1 Nasacort AQ (triamcinolone acetonide)
    • 3.3.2 Astelin (azelastine hydrochloride)
    • 3.3.3 Nasonex (mometasone furoate monohydrate)
    • 3.3.4 Singulair (Montelukast Sodium)
    • 3.3.5 Rhinocort Aqua (budesonide)
    • 3.3.6 Veramyst (fluticasone furoate)
    • 3.3.7 Xyzal (levocetirizine dihydrochloride)
    • 3.4 Key Takeaway
  • 4 Allergic Rhinitis Market: Pipeline Assessment
    • 4.1 Overview
    • 4.2 Strategic Pipeline Assessment
    • 4.2.1 Technology Trends Analytic Framework
    • 4.3 Allergic Rhinitis Market - Promising Drugs under Clinical Development
    • 4.4 Molecule Profile for Promising Drugs under Clinical Development
    • 4.4.1 Bilastine
    • 4.4.2 Sublivac (Extracts of allergens)
    • 4.4.3 Duonase (Azelastine + Fluticasone)
    • 4.4.4 GSK256066 (MDX-010, MDX-101)
    • 4.5 Allergic Rhinitis Market - Clinical Pipeline by Mechanism of Action
    • 4.5.1 Allergic Rhinitis - Phase III Clinical Pipeline
    • 4.5.2 Allergic Rhinitis - Phase II Clinical Pipeline
    • 4.5.3 Allergic Rhinitis- Phase I Clinical Pipeline
    • 4.5.4 Allergic Rhinitis - Preclinical Pipeline
    • 4.5.5 Allergic Rhinitis - List of Terminated Clinical Trials
    • 4.6 Key Takeaway
  • 5 Allergic Rhinitis Market: Implications for Future Market Competition
  • 6 Allergic Rhinitis Market: Future Players in the Allergic Rhinitis Market
    • 6.1 Introduction
    • 6.2 GlaxoSmithKline
    • 6.2.1 Company Overview
    • 6.2.2 Business Description
    • 6.3 Sanofi-Aventis
    • 6.3.1 Company Overview
    • 6.4 Novartis AG
    • 6.4.1 Company Overview
    • 6.4.2 Business Description
    • 6.5 AstraZeneca
    • 6.5.1 Overview
    • 6.5.2 Business Description
    • 6.6 Merck & Co
    • 6.6.1 Overview
    • 6.6.2 Business Description
  • 7 Allergic Rhinitis Market: Appendix
    • 7.1 Definitions
    • 7.2 Scope of Pipeline Research
    • 7.3 Abbreviations
    • 7.4 Research Methodology
    • 7.4.1 Coverage
    • 7.4.2 Secondary Research
    • 7.4.3 Forecasting
    • 7.4.4 Primary Research
    • 7.4.5 Expert Panels
    • 7.5 Contact Us
    • 7.6 Disclaimer
    • 7.7 Sources
  • 1.1 List of Tables
    • Table 1: Global Allergic Rhinitis Market Revenue ($bn) 2001- 2009
    • Table 2: Global Allergic Rhinitis Market Revenue ($bn) Forecast 2009-2017
    • Table 3: Major Marketed Products Analysis in the Allergic Rhinitis Market, 2010
    • Table 4: Allergic Rhinitis Therapeutics - Most Promising Drugs Under Clinical Development, 2010
    • Table 5: Allergic Rhinitis Therapeutics - Phase III Clinical Pipeline, 2010
    • Table 6: Allergic Rhinitis Therapeutics - Phase II Clinical Pipeline, 2010
    • Table 7: Allergic Rhinitis Therapeutics - Phase I Clinical Pipeline, 2010
    • Table 8: Allergic Rhinitis Therapeutics - Preclinical Pipeline, 2010
    • Table 9: Allergic Rhinitis Therapeutics - List of Terminated Clinical Trials, 2010
    • Table 10: GlaxoSmithKline - Respiratory Disease, Pipeline Portfolio, 2010
    • Table 11: Sanofi-Aventis - Respiratory Disease, Product Portfolio, 2010
    • Table 12: Novartis AG - Respiratory Disease, Pipeline Portfolio, 2010
    • Table 13: AstraZeneca - Respiratory Disease, Pipeline Portfolio, 2010
    • Table 14: Merck & Co - Respiratory Disease, Pipeline Portfolio, 2010
  • 1.2 List of Figures
    • Figure 1: Global Allergic Rhinitis Market 2001-2009
    • Figure 2: Global Allergic Rhinitis Market Forecast 2009-2017
    • Figure 3: Opportunity and Unmet Need in the Allergic Rhinitis Market, 2010
    • Figure 4: Strategic Competitor Assessment of the Major Marketed Products for Allergic Rhinitis, 2010
    • Figure 5: Pipeline Products by Phase of Development, 2010
    • Figure 6: Technology Trends Analytics Framework of the Allergic Rhinitis Pipeline, 2010
    • Figure 7: Technology Trends Analytic Framework of the Allergic Rhinitis Pipeline - Description, 2010
    • Figure 8: Allergic Rhinitis Market - Clinical Pipeline by Mechanism of Action, 2010
    • Figure 9: Allergic Rhinitis Market - Clinical Pipeline by Phase of Development, 2010
    • Figure 10: Implications for Future Market Competition in the Allergic Rhinitis Market, 2010
    • Figure 11: Allergic Rhinitis Therapeutics Market - Clinical Pipeline by Company, 2010
    • Figure 12: GlobalData Methodology
    • Figure 13: GlobalData Market Forecasting Model, 2010